-
HEALTHCARE & MEDICARE
BridgeBio performs well, Phase 3 data puts dwarfism drug on track for FDA filing
A drug developed by BridgeBio Pharma to target dwarfism increased children's growth rates in a pivotal clinical trial, achieving the…
Read More » -
HEALTHCARE & MEDICARE
Empathetic AI nurses could dramatically improve nurses’ work and patient care
Artificial intelligence nurses are no longer a futuristic concept. They are being tested and deployed in medical facilities around the…
Read More » -
HEALTHCARE & MEDICARE
Blinded by Science: The Importance of RWD and Post-Market Surveillance
The popularity of GLP-1 drugs has everyone talking about them, from Senela Williams' hype to South Park's satire. This heightened…
Read More » -
HEALTHCARE & MEDICARE
Why Mount Sinai chose Microsoft over Abridge and Suki
Leaders at New York's Mount Sinai Health System believe that, for now, Microsoft is the winner in environmental transcription. The…
Read More » -
HEALTHCARE & MEDICARE
Moderna says FDA's refusal to review mRNA flu vaccine violates federal rules and previous guidance
Moderna's messenger RNA flu vaccine was successful in two pivotal clinical trials, but the U.S. Food and Drug Administration refused…
Read More » -
FRAUD PREVENTION
B2B CFOs incorporate fraud controls into their cash flow strategy
Tradition is tradition. Traditionally, in many financial organizations, fraud protection has been in the same mental bucket as insurance premiums…
Read More » -
HEALTHCARE & MEDICARE
From claims payer to care partner: What artificial intelligence is really changing in health insurance, and what it's not
Health insurance has long been known as an industry of saying “no,” mailing confusing letters, and cleaning up administrative chaos…
Read More » -
HEALTHCARE & MEDICARE
Trust no one – Healthcare Blog
Author: Kim Berard You know, I've gotten to the point where I'm trying to ignore what Robert F. Kennedy, Jr.…
Read More » -
HEALTHCARE & MEDICARE
Evommune sets out to challenge Sanofi's Dupixent dominance in atopic dermatitis
When Evommune launched late last year, it said proof-of-concept testing data for one of its atopic dermatitis drug candidates would…
Read More » -
HEALTHCARE & MEDICARE
Solace Health reaches unicorn status by eliminating 'homework' in care
Healthcare startups welcomed a new unicorn on Tuesday, with Silicon Valley-based Solace Health closing a $130 million Series C round…
Read More »